Ratings by Leerink (Faisal A. Khurshid)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/5/2025 | Geron Corporation | GERN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/22/2025 | Galapagos NV | GLPG | Upgrade | Outperform (Market Perform) |
34.39 (27.73) |
-19.37% | Details | |
| 10/15/2025 | ANI Pharmaceuticals | ANIP | Maintain | Outperform (N/A) |
|
Details | ||
| 10/10/2025 | MannKind | MNKD | New Coverage | Outperform (N/A) |
5.14 (3.85) |
-25.1% | Details | |
| 9/25/2025 | Contineum Therapeutics | CTNM | New Coverage | Outperform (N/A) |
10.50 (14.98) |
42.67% | Details | |
| 8/14/2025 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | ANI Pharmaceuticals | ANIP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/30/2025 | Immunic Inc. | IMUX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/14/2025 | Ironwood Pharmaceuticals | IRWD | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/25/2025 | Zura Bio Ltd. | ZURA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2025 | Trevi Therapeutics | TRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2025 | Pliant Therapeutics | PLRX | Downgrade | Market Perform (Outperform) |
3.44 (1.07) |
-68.9% | Details | |
| 2/28/2025 | ANI Pharmaceuticals | ANIP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2025 | Ironwood Pharmaceuticals | IRWD | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/11/2024 | ANI Pharmaceuticals | ANIP | New Coverage | Outperform (N/A) |
59.16 (75.12) |
26.98% | Details | |
| 11/4/2024 | Zura Bio Ltd. | ZURA | New Coverage | Outperform (N/A) |
4.38 (5.78) |
31.96% | Details | |
| 10/11/2024 | Geron Corporation | GERN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/9/2024 | MannKind | MNKD | New Coverage | Outperform (N/A) |
5.93 (5.14) |
-13.32% | Details | |
| 9/9/2024 | Pliant Therapeutics | PLRX | New Coverage | Outperform (N/A) |
12.87 (1.07) |
-91.69% | Details | |
| 9/9/2024 | Trevi Therapeutics | TRVI | New Coverage | Outperform (N/A) |
2.95 (17.73) |
501.02% | Details | |
| 9/9/2024 | Immunic Inc. | IMUX | New Coverage | Outperform (N/A) |
1.34 (15.93) |
1088.81% | Details | |
| 9/9/2024 | Ironwood Pharmaceuticals | IRWD | New Coverage | Market Perform (N/A) |
4.51 (4.32) |
-4.21% | Details | |
| 9/9/2024 | Geron Corporation | GERN | New Coverage | Outperform (N/A) |
4.25 (1.57) |
-63.06% | Details |
